Cholangitis Global Clinical Trials Review, H1, 2013

News provided by

May 07, 2013, 04:21 ET

NEW YORK, May 7, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Cholangitis Global Clinical Trials Review, H1, 2013
http://www.reportlinker.com/p0829684/Cholangitis-Global-Clinical-Trials-Review-H1-2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_Discovery_and_Development

Summary

GlobalData's clinical trial report, "Cholangitis Global Clinical Trials Review, H1, 2013" provides data on the Cholangitis clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Cholangitis. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Cholangitis. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Cholangitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials by Country 8
Top Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Clinical Trials by BRIC Nations 14
Clinical Trials by G7 Nations 15
Clinical Trials in G7 Nations by Trial Status 16
Clinical Trials by E7 Nations 17
Clinical Trials in E7 Nations by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Unaccomplished Trials of Cholangitis 22
Subjects Recruited Over a Period of Time 24
Prominent Sponsors 25
Top Companies Participating in Cholangitis Therapeutics Clinical Trials 27
Prominent Drug Comparison 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Dr. Falk Pharma GmbH 30
Clinical Trial Overview of Dr. Falk Pharma GmbH 30
Gilead Sciences 31
Clinical Trial Overview of Gilead Sciences 31
Riemser Arzneimittel AG 32
Clinical Trial Overview of Riemser Arzneimittel AG 32
Bayer AG 33
Clinical Trial Overview of Bayer AG 33
Zambon Company S.p.A. 34
Clinical Trial Overview of Zambon Company S.p.A. 34
Toyama Chemical Co., Ltd. 35
Clinical Trial Overview of Toyama Chemical Co., Ltd. 35
Taiho Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of Taiho Pharmaceutical Co., Ltd. 36
Clinical Trial Overview of Top Universities / Institutes / Hospitals 37
Mayo Clinic 37
Clinical Trial Overview of Mayo Clinic 37
Academic Medical Centre 38
Clinical Trial Overview of Academic Medical Centre 38
Beth Israel Deaconess Medical Center 39
Clinical Trial Overview of Beth Israel Deaconess Medical Center 39
Stanford University 40
Clinical Trial Overview of Stanford University 40
Second Military Medical University 41
Clinical Trial Overview of Second Military Medical University 41
Karolinska University Hospital 42
Clinical Trial Overview of Karolinska University Hospital 42
Sahlgrenska University Hospital 43
Clinical Trial Overview of Sahlgrenska University Hospital 43
Universitatsklinikum Munster 44
Clinical Trial Overview of Universitatsklinikum Munster 44
Technische Universitat Munchen 45
Clinical Trial Overview of Technische Universitat Munchen 45
Johann Wolfgang Goethe University Hospitals 46
Clinical Trial Overview of Johann Wolfgang Goethe University Hospitals 46
Johns Hopkins University 47
Clinical Trial Overview of Johns Hopkins University 47
University Health Network 48
Clinical Trial Overview of University Health Network 48
Yale University 49
Clinical Trial Overview of Yale University 49
University of Heidelberg 50
Clinical Trial Overview of University of Heidelberg 50
The University of Tokyo 51
Clinical Trial Overview of The University of Tokyo 51
Cornell University 52
Clinical Trial Overview of Cornell University 52
Kyoto University 53
Clinical Trial Overview of Kyoto University 53
UMC Utrecht Holding BV 54
Clinical Trial Overview of UMC Utrecht Holding BV 54
University of Tennessee 55
Clinical Trial Overview of University of Tennessee 55
Hadassah Medical Organization 56
Clinical Trial Overview of Hadassah Medical Organization 56
Five Key Clinical Profiles 57
Appendix 76
Abbreviations 76
Definitions 76
Research Methodology 77
Secondary Research 77
About GlobalData 78
Contact Us 78
Disclaimer 78
Source 79

List of Tables

Cholangitis Therapeutics Market, Global, Clinical Trials by Zone, 2013* 7
Cholangitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Cholangitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Cholangitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2013* 10
Cholangitis Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 11
Cholangitis Therapeutics Clinical Trials, North America, Top Countries, 2013* 12
Cholangitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 13
Cholangitis Therapeutics Clinical Trials, BRIC Countries, 2013* 14
Cholangitis Therapeutics Clinical Trials, G7 Countries, 2013* 15
Cholangitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 16
Cholangitis Therapeutics Clinical Trials, E7 Countries, 2013* 17
Cholangitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 18
Cholangitis Therapeutics Market, Global, Clinical Trials by Phase, 2013* 19
Cholangitis Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 20
Cholangitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 21
Cholangitis Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 22
Cholangitis Therapeutics Market, Global, Terminated Clinical Trials, 2013* 23
Cholangitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Cholangitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 26
Cholangitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 28
Cholangitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Falk Pharma GmbH, 2013* 30
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, 2013* 31
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Riemser Arzneimittel AG, 2013* 32
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Bayer AG, 2013* 33
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Zambon Company S.p.A., 2013* 34
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Toyama Chemical Co., Ltd., 2013* 35
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Taiho Pharmaceutical Co., Ltd., 2013* 36
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2013* 37
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Academic Medical Centre, 2013* 38
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Beth Israel Deaconess Medical Center, 2013* 39
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2013* 40
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Second Military Medical University, 2013* 41
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska University Hospital, 2013* 42
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Sahlgrenska University Hospital, 2013* 43
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Universitatsklinikum Munster, 2013* 44
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Technische Universitat Munchen, 2013* 45
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johann Wolfgang Goethe University Hospitals, 2013* 46
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Johns Hopkins University, 2013* 47
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University Health Network, 2013* 48
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Yale University, 2013* 49
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2013* 50
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Tokyo, 2013* 51
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Cornell University, 2013* 52
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Kyoto University, 2013* 53
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by UMC Utrecht Holding BV, 2013* 54
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Tennessee, 2013* 55
Cholangitis Therapeutics Clinical Trials Market, Global, Clinical Trials by Hadassah Medical Organization, 2013* 56

List of Figures

Cholangitis Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 7
Cholangitis Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 8
Cholangitis Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 9
Cholangitis Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2013* 10
Cholangitis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 11
Cholangitis Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 12
Cholangitis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 13
Cholangitis Therapeutics Clinical Trials, G7 Countries (%), 2013* 15
Cholangitis Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 16
Cholangitis Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 18
Cholangitis Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 19
Cholangitis Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 20
Cholangitis Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 21
Cholangitis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 24
Cholangitis Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 25
Cholangitis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 27
Cholangitis Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 29
GlobalData Methodology 77